Diabetes 53:998-1006, 2004
© 2004 by the American Diabetes Association, Inc.
Metabotropic Glutamate Receptor Type 4 Is Involved in Autoinhibitory Cascade for Glucagon Secretion by -Cells of Islet of Langerhans
Shunsuke Uehara,
Akiko Muroyama,
Noriko Echigo,
Riyo Morimoto,
Masato Otsuka,
Shouki Yatsushiro, and
Yoshinori Moriyama
From the Department of Biochemistry, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, Japan
In islets of Langerhans, L-glutamate is stored in glucagon-containing secretory granules of -cells and cosecreted with glucagon under low-glucose conditions. The L-glutamate triggers secretion of -aminobutyric acid (GABA) from ß-cells, which in turn inhibits glucagon secretion from -cells through the GABAA receptor. In the present study, we tested the working hypothesis that L-glutamate functions as an autocrine/paracrine modulator and inhibits glucagon secretion through a glutamate receptor(s) on -cells. The addition of L-glutamate at 1 mmol/l; (R,S)-phosphonophenylglycine (PPG) and (S)-3,4-dicarboxyphenylglycine (DCPG), specific agonists for class III metabotropic glutamate receptor (mGluR), at 100 µmol/l; and (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) at 50 µmol/l inhibited the low-glucoseevoked glucagon secretion by 87, 81, 73, and 87%, respectively. This inhibition was dose dependent and was blocked by (R,S)-cyclopropyl-4-phosphonophenylglycine (CPPG), a specific antagonist of class III mGluR. Agonists of other glutamate receptors, including kainate and quisqualate, had little effectiveness. RT-PCR and immunological analyses indicated that mGluR4, a class III mGluR, was expressed and localized with - and F cells, whereas no evidence for expression of other mGluRs, including mGluR8, was obtained. L-Glutamate, PPG, and ACPT-I decreased the cAMP content in isolated islets, which was blocked by CPPG. Dibutylyl-cAMP, a nonhydrolyzable cAMP analog, caused the recovery of secretion of glucagon. Pertussis toxin, which uncouples adenylate cyclase and inhibitory G-protein, caused the recovery of both the cAMP content and secretion of glucagon. These results indicate that - and F cells express functional mGluR4, and its stimulation inhibits secretion of glucagon through an inhibitory cAMP cascade. Thus, L-glutamate may directly interact with -cells and inhibit glucagon secretion.
Address correspondence and reprint requests to Dr. Y. Moriyama, Department of Biochemistry, Faculty of Pharmaceutical Sciences, Okayama University, Okayama 700-8530, Japan. E-mail: moriyama{at}pheasant.pharm.okayama-u.ac.jp

CiteULike Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|